[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349854-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-349854-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","prognostic-pan-cancer-and-single-cancer-models-a-large-scale-analysis-using-a-real-world-clinico-genomic-database","Prognostic pan-cancer and single-cancer models - A large-scale analysis using a real-world clinico-genomic database","","Prognostic models in oncology shape personalized care, yet are often built within limited cohorts and vary in development and implementation. This study develops and benchmarks multiple machine learning models to predict survival across pan-cancer and 16 single-cancer settings using de-identified clinico-genomic data from 28,079 US cancer patients. Key shared predictors are identified, and pan-cancer models generally match or outperform single-cancer models, supporting risk stratification and transfer learning benefits.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-pan-cancer-and-single-cancer-models-a-large-scale-analysis-using-a-real-world-clinico-genomic-database/349854/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-pan-cancer-and-single-cancer-models-a-large-scale-analysis-using-a-real-world-clinico-genomic-database/349854.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is the purpose of the prognostic models studied in this paper?","Question",{"text":62,"@type":63},"They aim to predict patient survival and support risk stratification for personalized cancer care and treatment planning.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"What data and settings were used to benchmark the models?",{"text":67,"@type":63},"The study uses de-identified clinico-genomic data from 28,079 US patients and benchmarks models across pan-cancer and 16 single-cancer settings.",{"name":69,"@type":60,"acceptedAnswer":70},"How do pan-cancer models compare with single-cancer models?",{"text":71,"@type":63},"Pan-cancer models generally outperform or match single-cancer models for survival prediction and patient risk stratification, especially in smaller cohorts.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},349854,1790321994,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","OPEN ACCESS  \nCitation: McGough SF, Lyalina S, Incerti D, Huang Y, Tyanova S, Mace K, et al. (2026) Prognostic pan-cancer and single-cancer models: A large-scale analysis using a realworld clinico-genomic database. PLoS One 21(2): e0341355. [https://doi.org/10.1371/](https://doi.org/10.1371/)[ ](https://doi.org/10.1371/)[journal.pone.0341355](journal.pone.0341355)  \nEditor: Amy McCart Reed, The University of Queensland Faculty of Medicine, AUSTRALIA Received: June 13, 2025  \nAccepted: January 6, 2026  \nPublished: February 13, 2026  \nCopyright: © 2026 McGough et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData availability statement: The data underlying this study are owned by Flatiron Health, Inc. and Foundation Medicine, Inc. , and cannot be shared publicly due to third-party ownership and data use agreements that prohibit redistribution of the de-identified patient-level  \nRESEARCH ARTICLE  \nPrognostic pan-cancer and single-cancer models: A large-scale analysis using a real-world clinico-genomic database  \nSarah F. McGough1*, Svetlana Lyalina2, Devin Incerti3, Yunru Huang3, Stefka Tyanova3, Kieran Mace3, Chris Harbron4, Ryan Copping1, Balasubramanian Narasimhan5,6☯, Robert Tibshirani5,6☯*  \n1 Computational Sciences, Genentech Research and Early Development, Genentech, Inc. , South San Francisco, California, United States of America, 2 Safety Science, Product Development, Genentech, Inc. , South San Francisco, California, United States of America, 3 Data Sciences, Product Development, Genentech, Inc. , South San Francisco, California, United States of America, 4 Data Sciences, Product Development, F. Hoffmann-La Roche, Ltd. , Welwyn Garden City, United Kingdom, 5 Department of Statistics, Stanford University, Stanford, California, United States of America, 6 Department of Biomedical Data Sciences, Stanford University, Stanford, California, United States of America  \n☯ These authors contributed equally to this work.  \n* [mcgough.sarah@gene.com](mcgough.sarah@gene.com) (SFM); [tibs@stanford.edu](tibs@stanford.edu) (RT)  \nAbstract  \nPrognostic models in oncology have a profound impact on personalized cancer care and patient profiling, but tend to be heterogeneously developed and implemented in narrow patient cohorts. Here, we develop and benchmark multiple machine learning models to predict survival in pan-cancer and 16 single-cancer settings using ade-identified clinico-genomic database of 28,079 US patients with cancer. We identify key predictors of cancer prognosis, including 15 shared across seven or more cancer types, revealing strong consistency in cancer prognostic factors. We demonstrate that pan-cancer models generally outperform or match single-cancer models in predicting survival and risk stratifying patients, especially in smaller cancer cohorts, suggesting a unique transfer learning advantage of pan-cancer models. This work demonstrates the potential of pan-cancer approaches in enhancing the accuracy and applicability of prognostic models in oncology, paving the way for more personalized and effective cancer care strategies.  \nIntroduction  \nPrognostic models—models which predict a future health state, like survival  \n—have a direct and important impact in precision oncology. In clinical practice, prognosis informs personalized treatment and care management by helping identify the future course of illness, appropriate course of therapy (i.e. , ranging from aggressive treatment to surveillance), and resource allocation [ 1] . In clinical studies, stratifying patients into prognostic risk categories can aid in patient recruitment and  \nPLOS One | [https://doi.org/10.1371/journal.pone.0341355](https://doi.org/10.1371/journal.pone.0341355) February 13, 2026 1 / 23  \ndata. Requests for data sharing by license or by permission ","cbCaibQthHp8NFSI","https://ap.wps.com/l/cbCaibQthHp8NFSI","pdf",2945674,23,"English","# Abstract\n# Introduction\n## Prognostic models in precision oncology","[{\"question\":\"What is the purpose of the prognostic models studied in this paper?\",\"answer\":\"They aim to predict patient survival and support risk stratification for personalized cancer care and treatment planning.\"},{\"question\":\"What data and settings were used to benchmark the models?\",\"answer\":\"The study uses de-identified clinico-genomic data from 28,079 US patients and benchmarks models across pan-cancer and 16 single-cancer settings.\"},{\"question\":\"How do pan-cancer models compare with single-cancer models?\",\"answer\":\"Pan-cancer models generally outperform or match single-cancer models for survival prediction and patient risk stratification, especially in smaller cohorts.\"}]","Prognostic pan-cancer and single-cancer models - A large-scale analysis using a real-world clinico-genomic database | PDF",1790085989,58,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9525aff4a15b0c1182c8f8568cf77a09.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/771b6631c3350876fe81781e67755b73.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b6aa004df019965436c58ee59b812127.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e5ca51c56f85c34e51c55aa22aaeb36.webp",980,1268]